Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions

Xiaoling Long,Huan Zeng,Yun Zhang,Qiulong Lu,Zhao Cao,Hong Shu

DOI: https://doi.org/10.2147/jhc.s452628

2024-03-24

Journal of Hepatocellular Carcinoma

Abstract:Xiaoling Long, 1, &ast Huan Zeng, 1, &ast Yun Zhang, 1 Qiulong Lu, 1 Zhao Cao, 2 Hong Shu 1 1 Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 2 Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hong Shu, Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China, Tel +86 7715640296, Email Zhao Cao, Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Qingxiu District, Nanning, Guangxi, 530021, People's Republic of China, Tel +86 7715356724, Email Purpose: Developing a high-value, convenient, and validated differential diagnosis model to differentiate alpha-fetoprotein (AFP) negative hepatic occupying lesions and assist clinicians in early identification and intervention. Patients and Methods: A total of 340 patients with AFP-negative hepatic occupying lesions who were admitted to the Guangxi Medical University Cancer Hospital between August 2021 and April 2023 were included in the final retrospective analysis. The data were randomly divided into training and validation sets in a 7:3 ratio after performing multiple interpolations. In the training set, laboratory variables and models were screened using least absolute shrinkage and selection operator regression analysis, comparison of five machine learning algorithms, and univariate, as well as multivariate logistic regression analysis. A diagnostic prediction nomogram model was developed. We evaluated and validated the model using the receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA). Results: We identified six significant predictive factors from the results of multivariate logistic analysis in the training set and incorporated them into the nomogram model for diagnosing AFP-negative hepatic malignant occupying lesions (HMOL). The diagnostic nomogram, including gender, age, des-gamma-carboxy prothrombin (DCP), serum ferritin (SF), AFP, and hepatitis B surface antigen (HBsAg), achieved an area under the curve of 0.905 discriminated patients with HMOL from those with benign occupying lesions. Additionally, calibration curves demonstrated the close alignment between the nomogram predictions and the ideal curve, along with the consistency between predictions and actual results. Moreover, the DCA curves illustrated indicated benefit for all patients. These finding were confirmed by the validation set. Conclusion: The GADSAH model specifically targets the discrimination of malignant and benign liver lesions in AFP-negative patients. It offers a noninvasive, cost-effective, and efficient approach for diagnosing such cases. Keywords: hepatic occupying lesions, alpha-fetoprotein-negative, nomogram, diagnostic model Hepatic space-occupying lesions are abnormal tissue areas, comprising solid or cystic masses, located with the liver. Depending on the characteristics of the lesion, it can be categorized as either a malignant or a benign hepatic lesion. 1 However, it is essential to note that the treatment and prognosis for these two types of lesions differ significantly. Hepatic malignant occupying lesions (HMOL), primarily hepatocellular carcinoma (HCC), ranked sixth in incidence and third in mortality among global cancer diseases, as reported in the 2020 Global Cancer Statistics. 2,3 The incidence and mortality rates of HCC have shown a consistent increase worldwide over the last two decades. 4 Late diagnosis often leads to a poor prognosis for patients. Timely detection allows for liver transplant or surgical resection, which can result in a 5-year survival rate exceeding 70%. 5 In contrast, hepatic benign occupying lesions (HBOL), such as hepatic hemangiomas, generally exhibit slow growth and often require mere observation or local intervention. 6 Therefore, an accurate differential diagnosis of hepatic occupying lesions is crucial for developing appropriate treatment plans and predicting prognosis. The Current guidelines recommend screening for HCC using alpha-fetoprotein (AFP) and B-ultrasound. 7 However, as the proportion of small hepatocellular carcinomas being diagnosed continues to increase, the sensitivity of AFP progressively decreases. 8,9 Furthermore, studies have shown that approximately 30% to 40% of HCC -Abstract Truncated-

oncology